Contents

Current Medicinal Chemistry, Volume 21 - Number 31

Editorial

Editorial (Thematic Issue: Emerging Biomarkers for Drug Development in Amyotrophic Lateral Sclerosis)

, 21(31): 3507

Sebastiano Cavallaro


DOI: 10.2174/092986732131140918141824




Cell to Cell Spreading of Misfolded Proteins as a Therapeutic Target in Motor Neuron Disease

, 21(31): 3508 - 3534

Livia Pasquali, Paola Lenzi, Francesca Biagioni, Gabriele Siciliano and Francesco Fornai


DOI: 10.2174/0929867321666140601161534




Biomarkers and Future Targets for Development in Amyotrophic Lateral Sclerosis

, 21(31): 3535 - 3550

Parvathi Menon, Matthew C. Kiernan and Steve Vucic


DOI: 10.2174/0929867321666140601161148




The Glutamate Hypothesis in ALS: Pathophysiology and Drug Development

, 21(31): 3551 - 3575

H. Blasco, S. Mavel, P. Corcia and P.H. Gordon


DOI: 10.2174/0929867321666140916120118




Therapeutic Targeting of Epigenetic Components in Amyotrophic Lateral Sclerosis (ALS)

, 21(31): 3576 - 3582

J. Lee, H. Ryu, G. Keum, Y.J. Yoon, N.W. Kowall and H. Ryu


DOI: 10.2174/0929867321666140706131825




Potential Therapeutic Drugs and Methods for the Treatment of Amyotrophic Lateral Sclerosis

, 21(31): 3583 - 3593

G. Yacila and Y. Sari


DOI: 10.2174/0929867321666140601162710




Interaction of Chemokines with their Receptors - From Initial Chemokine Binding to Receptor Activating Steps

, 21(31): 3594 - 3614

Stefanie Thiele and Mette Marie Rosenkilde


DOI: 10.2174/0929867321666140716093155




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science